NURS 510 DQ federal law or regulation related to patient safety
NURS 510 DQ federal law or regulation related to patient safety
DQ1 Select a state or federal law or regulation related to patient safety that has been implemented within the last five years requiring hospitals or any other health care organizations to change the way they manage the delivery of care. Discuss the changes that have occurred because of this law or regulation.
Additionally, discuss the technology associated with either your selected law/regulation or a similar one. Are there ethical dilemmas that have resulted from technology changes when delivering care to patients or patient safety? Explain the dilemmas and how they might be resolved.
DQ2 Evidence-based practice is extremely important in nursing. Throughout your master’s program, you will complete research on various topics. Knowing how to construct a strong problem statement and complete a critical analysis of the available information to write a literature review is essential.
This week, you will write a problem statement and perform a literature review in preparation for your ethical issues debate presentation. Share your problem statement in this discussion so that you can review each other’s work and provide peer-to-peer feedback. Also, describe what you think are the most important learning takeaways from the literature review resources you reviewed.
Follow the instructions in the bullets below to direct you where to find resources on problem statements and literature reviews:
Go to the Student Resources tab on the top of your Blackboard page.
Click on Writing Resources.
Click on Research and Writing.
Click on Writing Strategies.
Then view:
Writing a Problem Statement
What is a Literature Review
Conducting a Literature Review
The Patient Safety Rule, published in the Federal Register on November 21, 2008, effective on January 19, 2009, is codified at 42 C.F.R. Part 3 (73 FR 70732). The Patient Safety Rule implements select provisions of PSQIA.
OCR has responsibility for interpreting and implementing the confidentiality protections described in Subpart C and the enforcement provisions described in Subpart D.
AHRQ has responsibility for listing and delisting of patient safety organizations (PSOs) described in Subpart B.
Subpart A defines essential terms, such as patient safety work product, patient safety evaluation system, and PSO.
Subpart B provides the requirements for listing PSOs. These entities offer their expert advice in analyzing the patient safety events and other information they collect or develop to provide feedback and recommendations to providers.
Subpart C describes the privilege and confidentiality protections that attach to patient safety work product and the exceptions to the protections.
Subpart D establishes a framework to enable HHS to monitor and ensure compliance with the confidentiality provisions, a process for imposing a civil money penalty for breach of the confidentiality provisions, and hearing procedures.
